Format

Send to

Choose Destination
Rheumatology (Oxford). 2014 Dec;53(12):2312-4. doi: 10.1093/rheumatology/keu344. Epub 2014 Sep 17.

Treatment of Erdheim-Chester disease with canakinumab.

Author information

1
Department of Pediatrics, Nîmes University Hospital, Nîmes, INSERM U 844, University of Montpelier 1, Montpellier, Department of Pediatric Radiology, Department of Pediatrics, Assistance Publique Hôpitaux de Paris, Bicêtre University Hospital, Le Kremlin Bicêtre, University of Poitiers, Laboratoire Inflammation, Tissus Epithéliaux et Cytokines (LITEC) Poitiers, Laboratory of Genetics, Rare and Autoinflammatory Diseases, Department of Genetics, LBM - Montpellier University Hospital, INSERM U844, Montpellier and Department of General Pediatrics and Internal Medicine, Assistance Publique Hôpitaux de Paris, Robert Debré University Hospital, University of Paris, Paris, France. tu-anh.tran@chu-nimes.fr.
2
Department of Pediatrics, Nîmes University Hospital, Nîmes, INSERM U 844, University of Montpelier 1, Montpellier, Department of Pediatric Radiology, Department of Pediatrics, Assistance Publique Hôpitaux de Paris, Bicêtre University Hospital, Le Kremlin Bicêtre, University of Poitiers, Laboratoire Inflammation, Tissus Epithéliaux et Cytokines (LITEC) Poitiers, Laboratory of Genetics, Rare and Autoinflammatory Diseases, Department of Genetics, LBM - Montpellier University Hospital, INSERM U844, Montpellier and Department of General Pediatrics and Internal Medicine, Assistance Publique Hôpitaux de Paris, Robert Debré University Hospital, University of Paris, Paris, France.
PMID:
25234662
DOI:
10.1093/rheumatology/keu344
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center